With the FCC on the verge of repealing net neutrality rules, there's considerable uncertainty about how the change will affect the healthcare industry, with telemedicine, particularly for rural hospitals, up in the air.
Lawmakers bought themselves a couple of more weeks to hammer out a spending bill, but long-term funding for CHIP and community health centers remains in question.
A suburban New York City woman has sued a doctor, claiming he used his cellphone to take a language test while operating on her.
Either Dr. Salomon Melgen is one of the biggest Medicare swindlers ever, stealing more than $100 million from the federal healthcare program, or a penny-ante thief who walked off with $64,000.
In response to the 21st Century Cures Act, the FDA outlined its regulatory approach in guidance documents about software as a medical device.
The agency's final guidance on additive manufacturing gives developers a clear pathway for getting their 3-D printed products approved.
Earlier this year, lawmakers feared they would need to pass a VA Choice funding extension quickly as current funds dwindled. Now, Congress may hold off on the bill until funds run out in 2018.
Centrus Premier Home Care Inc. allegedly billed Massachusetts' Medicaid program for services that were not eligible for reimbursement. It will pay $14 million to settle the allegations.
The once-a-week shot for people with Type 2 diabetes reduces blood sugar levels and can also reduce appetite.
Prosecutors say a prominent Florida eye doctor accused of bribing Democratic Sen. Bob Menendez of New Jersey should get a 30-year sentence for a separate Medicare fraud scheme that they say stole more than $100 million from the federal government.
The Senate health committee will get its first crack at assessing the Trump administration's implementation of last year's key bipartisan healthcare law.
The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthly dose.